戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 om its established signaling function in the portal circulation.
2 oxin within the gut lumen and its associated portal circulation.
3 ts constant exposure to foreign Ags from the portal circulation.
4 ial TLR ligands, which are delivered via the portal circulation.
5 he amino acid methionine or absorbed via the portal circulation.
6 ctor substances into the intestinal wall and portal circulation.
7  infused via intrasplenic injection into the portal circulation.
8 tes as direct vector administration into the portal circulation.
9  to export iron out of the cell and into the portal circulation.
10 bution in arterial, deep venous, and hepatic portal circulation.
11 uctose uptake and transport into the hepatic portal circulation.
12 s of >50% or the release of lactate into the portal circulation.
13 allogeneic hepatocytes transplanted into the portal circulation.
14 ation via the gut lymphatics rather than the portal circulation.
15 ried in the mesenteric lymph rather than the portal circulation.
16 ct delivery of the same vector dose into the portal circulation (1.3+/-0.3 microg/mL, or 26% of norma
17     When microspheres were injected into the portal circulation after nitroglycerine administration,
18                 Islets were infused into the portal circulation after transhepatic access.
19 ns, is present at high concentrations in the portal circulation and thus may play an important role i
20  the TMA produced is passively absorbed into portal circulation, and hepatic flavin-dependent monooxy
21 l permeability, release of microbes into the portal circulation, and increased serum levels and liver
22 uivocally that: (a) receptors in the coeliac-portal circulation are more sensitive in amplifying gast
23  of gut-derived antigens that arrive through portal circulation at homeostasis and protect these orga
24 tricular nucleus (PVN) and released into the portal circulation at the median eminence, is known to p
25    Repeated AVP/CRF release in the pituitary portal circulation, due to stress, sensitizes and potent
26                                          The portal circulation has a distinct immunological milieu c
27 s the ileocyte basolateral membrane into the portal circulation have not been fully identified.
28 p<.01) and the gut released lactate into the portal circulation in all animals.
29 nsible for hepatic uptake of bile acids from portal circulation is Na+-taurocholate cotransporting po
30    The hepatic uptake of bile acids from the portal circulation is primarily dependent upon a sodium-
31 gh influx of TLR4 and TLR9 agonists into the portal circulation, leading to enhanced hepatic tumour-n
32 rved from 4 vectors after injection into the portal circulation of immunodeficient mice.
33 titrypsin (alpha-1AT) were injected into the portal circulation of immunodeficient mice.
34 des direct evidence for enhanced entrance to portal circulation of LPS enterally administered to the
35 f insulin secretion from beta-cells into the portal circulation of the islet during hypoglycemia is a
36 t of schistosomiasis, resides in the hepatic portal circulation of their human host up to 30 years wi
37 r level, microspheres were injected into the portal circulation of these animals.
38 le for basolateral bile acid export into the portal circulation remains to be determined.
39 suicide gene by RCR vectors infused into the portal circulation results in progressive transduction o
40 livered directly to the liver, via recipient portal circulation, stimulated long-term, high magnitude
41 creased levels of bacterial endotoxin in the portal circulation, suggesting a role for gut-derived to
42 y secreting inflammatory adipokines into the portal circulation that drains visceral fat, we determin
43  factor (CRF) into the hypothalamo-pituitary portal circulation, thereby stimulating adrenocorticotro
44 h the mucosal barrier and travel through the portal circulation to the liver, where they cause absces
45   Allogeneic hepatocytes introduced into the portal circulation via intrasplenic injection are immuno
46 ologically active MAMPs translocate into the portal circulation, with flagellin (Toll-like receptor 5

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。